• Profile
Close

Neuropsychological outcomes of children 1 year after pediatric cardiac arrest: Secondary analysis of 2 randomized clinical trials

JAMA Dec 14, 2018

Slomine BS, et al. - Researchers performed secondary analysis of cardiac arrest (CA) survivors enrolled in the Therapeutic Hypothermia After Pediatric Cardiac Arrest In-Hospital (THAPCA-IH) and Out-of-Hospital (THAPCA-OH) trials, to describe their neuropsychological outcomes. They also compare the results with the primary outcome measure for these trials. Although 71.2% of the survivors had favorable caregiver-rated outcomes 1 year later, the survivors displayed significant performance-based neuropsychological deficits across measures.

Methods

  • Participants of this secondary analysis comprised 222 CA survivors, aged 1 to 18 years who received chest compressions for 2 minutes or more, remained comatose and required mechanical ventilation after return of circulation.
  • These participants were enrolled in targeted temperature-management trials from 41 pediatric intensive care units.
  • Collection of data was done from September 3, 2009, to February 3, 2016, and analysis was done from March 10, 2017, to April 20, 2018.
  • Pre-CA functioning within 24 hours after enrollment was evaluated using the Vineland Adaptive Behavior Scales, Second Edition (VABS-II), a standardized measure of neurobehavioral functioning based on caregiver report (age-corrected mean [SD] scores = 100 [15]); VABS-II<70 indicated significant developmental delays; completion of VABS-II and neuropsychological testing was done 1 year after CA.
  • The Mullen Scales of Early Learning (Mullen) was used for neuropsychological testing in children younger than 6 years; neuropsychological testing in older children was done determining the Wechsler Abbreviated Scale of Intelligence (WASI) and neuropsychological measures of attention, memory, processing speed, and executive functioning.

Results

  • Neuropsychological testing was completed by 160 participants [96 (60.0%) were male; the median (interquartile range [IQR]) age was 2.5 years (1.3-6.1 years)].
  • Of these, 96 (60.0%) were white, 41 (25.6%) were black, and 23 (14.4%) were of other/unknown race; 343 (21.2%) were Hispanic or Latino; 119 (74.4%) were non-Hispanic or Latino; and 7 (4.4%) were of unknown ethnicity.
  • Researchers classified 114 participants (71.2%) as having favorable outcomes (VABS-II ≥70).
  • The participants displayed impairments (>2 SD below the mean for age) ranging from 7% to 61% across neuropsychological measures.
  • Younger children displayed strong correlations (Mullen, r = 0.69-0.87) between global cognitive and VABS-II scores but older children showed moderate correlations (r = 0.21-0.54 for the WASI).
  • Global cognitive impairment was evident in 25.2% and selective neuropsychological deficits were noted in 30 of 35 older children (85.7%) among the 111 children with favorable outcomes on VABS-II.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay